Evaluating the anti-tumor potential of PARP inhibitor treatment in combination with dendritic cell-based therapies in triple negative breast cancer
Targeting radiotherapy resistance in Head and Neck Cancers: the potential biomarker role of TIPRL1 and CIP2A, two cellular inhibitors of Protein Phosphatase 2A
Deciphering the dendritic cell compartment in ovarian cancer to assess their potential as tumor vaccines.
HBOC (Hereditary Breast and Ovarian Cancer), a paradigm shift for counseling and treatment of patients with defects in homologous recombination - an explorative study
Evaluation of different methods to assess homologous recombination status and sensitivity to PARP inhibitors in ovarian cancer